The recent VdE debate on the Healing Innovation blog forced me to reconsider what drives innovation in medical devices. A reduced pool of money clearly hurts innovation, which is our current situation due to the lack of regulatory visibility and healthcare reimbursement concerns. But, under the same financial constraints, what has a greater impact on innovation, the process or the people?
Last week the Healing Innovation website posted a blog asking whether Value-driven Engineering (VdE) is the solution to the recent challenges to innovation in the medical device industry and whether the PR on the initiative overstates the impact relative to the content of the movement. And, fundamentally is the process in itself actually innovative? The leadership at the Austen BioInnovation Institute in Akron (ABIA), after reading the post, felt that a few of the assertions are flawed and requested an opportunity to respond. The following is that response: Read More
